Stockscreener 앱 받기
29.14
3.12%
-0.88
전일 마감가:
$30.02
열려 있는:
$29.98
하루 거래량:
353.84K
Relative Volume:
0.60
시가총액:
$1.59B
수익:
$447.57M
순이익/손실:
$-38.92M
주가수익비율:
-35.11
EPS:
-0.83
순현금흐름:
$-1.15M
1주 성능:
-13.62%
1개월 성능:
-7.11%
6개월 성능:
-18.01%
1년 성능:
+39.22%
1일 변동 폭
$28.85
$30.12
1주일 범위
$28.29
$35.60
52주 변동 폭
$18.94
$43.11
Atricure Inc Stock (ATRC) Company Profile
명칭
Atricure Inc
전화
513-755-4100
주소
7555 INNOVATION WAY, MASON, OH
ATRC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
29.08 | 1.59B | 447.57M | -38.92M | -1.15M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
534.61 | 184.23B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
168.20 | 48.46B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
98.03 | 47.15B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
241.08 | 35.24B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.31 | 16.39B | 3.90B | 392.30M | 288.10M | 1.95 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 재개 | JP Morgan | Overweight |
| 2024-04-23 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-29 | 개시 | UBS | Buy |
| 2021-08-05 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 재확인 | Needham | Buy |
| 2020-11-06 | 재확인 | Needham | Buy |
| 2020-04-07 | 개시 | Oppenheimer | Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-24 | 재확인 | Needham | Buy |
| 2019-08-13 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | 개시 | JP Morgan | Overweight |
| 2018-10-04 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Stifel | Buy |
| 2018-06-18 | 재확인 | Needham | Buy |
| 2018-04-27 | 재확인 | Needham | Buy |
| 2018-01-16 | 재확인 | Needham | Buy |
| 2017-11-02 | 재확인 | Needham | Buy |
| 2017-07-28 | 재확인 | Needham | Buy |
| 2017-05-30 | 재개 | Piper Jaffray | Overweight |
| 2016-06-30 | 재개 | JMP Securities | Mkt Outperform |
| 2015-10-28 | 재확인 | Needham | Buy |
| 2015-10-06 | 재확인 | Canaccord Genuity | Buy |
| 2015-10-06 | 재확인 | Needham | Buy |
모두보기
Atricure Inc 주식(ATRC)의 최신 뉴스
Left Atrial Appendage Closure Market to Set Phenomenal Growth - openPR.com
AtriCure, Inc. (NASDAQ:ATRC) Q1 2025 Earnings Call Transcript - Insider Monkey
Shareholders in AtriCure (NASDAQ:ATRC) have lost 40%, as stock drops 11% this past week - Yahoo Finance
AtriCure, Inc. (NASDAQ:ATRC) Screens Well But There Might Be A Catch - simplywall.st
Needham cuts AtriCure stock target to $44, maintains buy rating By Investing.com - Investing.com Nigeria
AtriCure price target lowered to $52 from $58 at BTIG - TipRanks
AtriCure price target lowered to $51 from $52 at Canaccord - TipRanks
AtriCure’s Strong Q1: Revenue Growth and Challenges - TipRanks
Needham cuts AtriCure stock target to $44, maintains buy rating - Investing.com Australia
UBS Adjusts AtriCure (ATRC) Price Target Amid Core Business Stre - GuruFocus
AtriCure, Inc. SEC 10-Q Report - TradingView
UBS Adjusts Price Target on AtriCure to $58 From $60, Maintains Buy Rating - marketscreener.com
14 Analysts Assess AtriCure: What You Need To Know - Benzinga
AtriCure (ATRC) Target Price Revised Amid Mixed Sector Performan - GuruFocus
Visa To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
AtriCure (ATRC) Buy Rating Reaffirmed Despite Adjusted Price Tar - GuruFocus
JMP maintains AtriCure stock $60 target post 1Q25 results - Investing.com
JMP maintains AtriCure stock $60 target post 1Q25 results By Investing.com - Investing.com India
AtriCure Inc (ATRC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
(ATRC) Investment Report - news.stocktradersdaily.com
AtriCure, Inc. Reports Strong Q1 2025 Growth - TipRanks
AtriCure Inc (ATRC) Q1 2025 Earnings: EPS of -$0.14 Beats Estima - GuruFocus
Earnings call transcript: AtriCure Q1 2025 beats EPS expectations, stock up 2.9% - Investing.com Nigeria
ATRC Revenue Forecast for 2025 and Earnings Outlook | ATRC Stock News - GuruFocus
AtriCure (ATRC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
AtriCure Reports First Quarter 2025 Financial Results - BioSpace
AtriCure (ATRC) Exceeds Q1 Revenue Expectations with Strong Prod - GuruFocus
ATRICURE Earnings Results: $ATRC Reports Quarterly Earnings - Nasdaq
Earnings Flash (ATRC) ATRICURE INC. Posts Q1 Revenue $123.6M, vs. FactSet Est of $122.9M - marketscreener.com
AtriCure: Q1 Earnings Snapshot - marketscreener.com
Medical Device Giant AtriCure Posts Double-Digit Growth: Q1 Revenue Hits $124M as Margins Expand - Stock Titan
AtriCure Earnings Preview - Benzinga
Press Release Distribution & PR Platform - ACCESS Newswire
Left Appendage Occlusion Device Market Top Companies Study - openPR.com
Cryoablation Market Set to Witness Significant Growth by 2032 | - openPR.com
AtriCure Announces First Use of the AtriClip PRO-Mini® Device | ATRC Stock News - GuruFocus
AtriCure Announces First Use of the AtriClip PRO-Mini® Device | - GuruFocus
AtriCure launches smaller device for heart surgery By Investing.com - Investing.com South Africa
AtriCure announces first use of newest AtriClip device - MassDevice
AtriCure Reports 1st Use of Newest AtriClip LAA Exclusion System - Medical Product Outsourcing
AtriCure launches smaller device for heart surgery - Investing.com Australia
AtriCure Announces First Use of the AtriClip PRO-Mini® Device - Yahoo Finance
Dayton’s stocks continue loss streak following election and now tariffs - The Business Journals
AtriCure Drops 25%: Bargain Or Caution Sign? (NASDAQ:ATRC) - Seeking Alpha
AtriCure to Announce First Quarter 2025 Financial Results - MarketScreener
Is AtriCure (NASDAQ:ATRC) A Risky Investment? - simplywall.st
JMP maintains AtriCure stock with $60 target post-Investor Day By Investing.com - Investing.com Canada
Atricure Inc (ATRC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.65%
0.37%
자본화:
|
볼륨(24시간):